Cargando…
Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling
OBJECTIVE: In visceral obesity, an overactive endocannabinoid/CB(1) receptor (CB(1)R) system promotes increased caloric intake and decreases energy expenditure, which are mitigated by global or peripheral CB(1)R blockade. In mice with diet-induced obesity (DIO), inhibition of food intake by the peri...
Autores principales: | Tam, Joseph, Szanda, Gergő, Drori, Adi, Liu, Ziyi, Cinar, Resat, Kashiwaya, Yoshihiro, Reitman, Marc L., Kunos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641628/ https://www.ncbi.nlm.nih.gov/pubmed/29031713 http://dx.doi.org/10.1016/j.molmet.2017.06.010 |
Ejemplares similares
-
Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3
por: Szanda, Gergő, et al.
Publicado: (2023) -
CB(1)R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
por: Drori, Adi, et al.
Publicado: (2020) -
Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity‐induced chronic kidney disease
por: Udi, Shiran, et al.
Publicado: (2019) -
SUN-665 Peripheral CB(1)R Blocker Improves Metabolism in Diet Induced Obese Mice Independent of Hepatic FGF21
por: Liu, Jie, et al.
Publicado: (2020) -
Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue
por: Godlewski, Grzegorz, et al.
Publicado: (2015)